A lawsuit against Bozeman Health Deaconess Hospital in Bozeman, Montana, alleges that the hospital has been involved in a kickback scheme with Advanced Medical Imaging, a Bozeman radiology group. 

In 1994, Johns Hopkins University’s Ruth Faden led a White House investigation into “widespread radiation experiments” on human test subjects. The following year, Faden and the Advisory Committee on Human Radiation Experiments (ACHRE) issued a report on the subject. This week, the Johns Hopkins Berman Institute of Bioethics hosted a day-long symposium in honor of the report’s impact.

Radiologists contribute to medicine in very specific ways. Imaging directly impacts patient outcomes, such as decreased mortality across a population that undergoes cancer screening. It can also reduce overall costs, for example, by demonstrating that an expensive surgery is not necessary. These factors combine to form imaging’s third impact: It can reduce the length of an episode of care. However, current metrics are not designed with these unique facets of radiology in mind.   

Jubilant Pharma announced U.S. Food and Drug Administration (FDA) approval for a rubidium-82 generator used to deliver patient doses of rubidium for imaging procedures. Named RUBY-FILL, the device is geared towards PET myocardial perfusion imaging and is expected to be available befor the end of the year.

Danny Hughes, PhD, Senior Director of the Harvey L. Neiman Health Policy Institute in Reston, Virginia, spoke to Radiology Business about radiology’s role in shared savings programs (SSPs), as well as future roles for imaging in these new reimbursement models.

The leaves are changing, pumpkin spice lattes are everywhere and the world has gone pink for Breast Cancer Awareness month. Welcome back, October.

Multiple patient advocacy groups and healthcare organizations, including the American College of Radiology (ACR) and Society of Breast Imaging (SBI), are asking Congress to extend a federal mandate that requires insurance companies to fully insure annual mammograms for women 40 years old and older. 

A wearable device that senses electronic brain activity and diagnoses brain damage received clearance from the U.S. Food and Drug Administration, allowing BrainScope to market the product commercially.